查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1726270

全球分子影像市场：市场规模、份额、趋势分析（按模式、应用、最终用途和地区）、细分市场预测（2025-2030 年）

Molecular Imaging Market Size, Share, & Trends Analysis Report By Modality (Molecular Ultrasound Imaging, Positron Emission Tomography), By Application (Cardiovascular, Neurology), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

分子影像市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球分子影像市场规模预计到2030年将达到114亿美元，2025年至2030年期间的复合年增长率为4.6%。

推动该市场成长的关键因素包括技术进步、癌症盛行率上升以及研发投入增加。例如，根据国际癌症研究机构的数据，2022年全球将报告约19,976,499例新发癌症病例和9,743,832例癌症相关死亡病例。

癌症、心血管疾病和神经系统疾病等慢性疾病的盛行率不断上升，需要有效的诊断工具，预计这将对分子影像市场的成长做出重大贡献。 PET（正子断层扫描）、SPECT（单光子发射电脑断层扫描）和NMR（核磁共振）波谱仪等分子影像仪器在这方面特别有效。这些先进的技术提供了与各种疾病相关的代谢过程、分子活动和结构变化的详细见解。这些使医疗专业人员能够以高精度和准确度观察和评估肿瘤、心臟功能和神经系统异常的程度和特征。

此外，分子影像可以促进疾病的早期发现，即使是在亚临床阶段，也可以实现及时干预和个人化治疗方案。这种积极主动的方法不仅改善了患者的治疗效果，而且还降低了与晚期疾病和併发症相关的医疗成本。

市场主要企业采取的策略性倡议，如併购、产品发布、监管部门核准、合作、协作以及研发 (R&D) 活动，在推动分子影像市场成长方面发挥着至关重要的作用。例如，2024 年 1 月，布鲁克公司在俄亥俄州立大学国家门户超高场核磁共振中心成功安装了最先进的 1.2吉赫(GHz) 核磁共振系统。此 GHz 级 NMR 系统代表了核磁共振 (NMR) 光谱的重大进步，旨在彻底改变生命和材料科学研究。

分子影像市场报告重点

  • 根据模式，单光子放射电脑断层扫描 (SPECT) 部分将在 2024 年占据主导地位，份额为 43.3%。
  • 核磁共振 (NMR) 波谱仪领域预计将成为成长最快的领域，2025 年至 2030 年的复合年增长率为 8.8%。
  • 根据应用，由于全球癌症发病率上升以及对先进诊断解决方案的需求不断增加，肿瘤学领域在 2024 年占据了最大的市场占有率。
  • 根据最终用途，由于临床环境中越来越多地采用先进的影像技术，医院部门预计将在 2024 年占据最大的市场占有率。
  • 在预测期内，诊断影像中心部分预计将成长最快，因为与大型医院相比，诊断影像中心能够提供高品质、专业的影像诊断，且週转时间更短。
  • 到 2024 年，北美将占据市场主导地位，占有 41.4% 的份额。

目录

第一章 分析方法与范围

第二章执行摘要

第三章 分子影像市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 分子影像市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析

第四章分子影像市场：按模式的估计和趋势分析

  • 特定于模式的仪表板
  • 分子影像市场：按模式变异分析
  • 全球分子影像市场：按模式分類的市场规模和趋势分析（2018-2030）
  • 分子超音波成像
  • 正子断层扫描（PET）
  • 单光子发射电脑断层扫描（SPECT）
  • 核磁共振（NMR）波谱仪
  • 其他的

第五章分子影像市场：按应用的估计和趋势分析

  • 用于特定目的的仪表板
  • 分子影像市场：应用趋势分析
  • 全球分子影像市场：按应用分類的市场规模和趋势分析（2018-2030）
  • 心血管系统
  • 神经病学
  • 肿瘤学
  • 呼吸系统
  • 胃肠道

第六章分子影像市场：按最终用途的估计和趋势分析

  • 按最终用途分類的仪表板
  • 分子影像市场：依最终用途的变化分析
  • 全球分子影像市场：按最终用途分類的市场规模和趋势分析（2018-2030 年）
  • 医院
  • 诊断影像中心
  • 研究所

第七章分子影像市场：区域估计与趋势分析

  • 市场仪表板：按地区
  • 各地区市场占有率分析（2024 年及 2030 年）
  • 分子影像市场：按地区分類的关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要企业热力图分析（2024年）
  • 公司简介
    • Bruker
    • GE HealthCare
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Mediso Ltd.
    • Cubresa Inc.
    • Shimadzu Corporation
    • United Imaging Healthcare Co., Ltd.
    • Positron
Product Code: GVR-4-68040-374-6

Molecular Imaging Market Growth & Trends:

The global molecular imaging market size is estimated to reach USD 11.4 billion by 2030, expanding at a CAGR of 4.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include technological advancements, increase in prevalence of cancer, and rising investment in R&D. For instance, according to the International Agency for Research on Cancer, approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths were reported globally in 2022.

The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates effective diagnostic tools, which are expected to significantly contribute to the growth of the molecular imaging market. Molecular imaging devices such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and Nuclear Magnetic Resonance (NMR) Spectrometer are particularly efficient in this regard. These advanced technologies provide detailed insights into the metabolic processes, molecular activities, and structural changes associated with various diseases. They enable healthcare professionals to visualize and assess the extent and characteristics of tumors, cardiac function, and neurological abnormalities with high precision and accuracy.

Moreover, molecular imaging facilitates early detection of diseases, even at subclinical stages, allowing for timely intervention and personalized treatment planning. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with advanced disease stages and complications.

Strategic initiatives undertaken by major market players, including mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, and research and development (R&D) activities, play a crucial role in driving the growth of the molecular imaging market. For instance, in January 2024, Bruker Corporation successfully installed a state-of-the-art 1.2 Gigahertz (GHz) NMR system at The Ohio State University's National Gateway Ultrahigh Field NMR Center. This GHz-class NMR system represents a significant advancement in nuclear magnetic resonance (NMR) spectroscopy, aiming to revolutionize research in life sciences and materials science.

Molecular Imaging Market Report Highlights:

  • Based on the modality segment, the Single Photon Emission Computed Tomography (SPECT) segment dominated by capturing a share of 43.3% in 2024
  • The Nuclear Magnetic Resonance (NMR) spectrometer segment is anticipated to be the fastest-growing segment, with a CAGR of 8.8% from 2025 to 2030.
  • Based on application, Oncology segment accounted for the largest market share in 2024 due to the rising global cancer burden and the growing demand for advanced diagnostic solutions.
  • Based on end use, Hospitals segment held the largest market share in 2024 due to the increasing adoption of advanced imaging technologies in clinical settings.
  • The diagnostic imaging centers segment is projected to be the fastest-growing segment over the forecast period, driven by the ability to offer high-quality, specialized imaging procedures with efficient turnaround times compared to larger hospitals.
  • North America dominated the market with a share of 41. 4% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Molecular Imaging Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Molecular Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Molecular Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Modality Segment Dashboard
  • 4.2. Molecular Imaging Market: Modality Movement Analysis
  • 4.3. Global Molecular Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 4.4. Molecular Ultrasound Imaging
    • 4.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 4.5. Positron Emission Tomography (PET)
    • 4.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 4.6. Single Photon Emission Computed Tomography (SPECT)
    • 4.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 4.7. Nuclear Magnetic Resonance (NMR) Spectrometer
    • 4.7.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 5. Molecular Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Molecular Imaging Market: Application Movement Analysis
  • 5.3. Global Molecular Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Cardiovascular
    • 5.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 5.5. Neurology
    • 5.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 5.7. Respiratory
    • 5.7.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 5.8. Gastrointestinal
    • 5.8.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 6. Molecular Imaging Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Molecular Imaging Market: End Use Movement Analysis
  • 6.3. Global Molecular Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Imaging Centers
    • 6.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 6.6. Research Institutes
    • 6.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 7. Molecular Imaging Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Molecular Imaging Market by Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. U.K.
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. U.K. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Germany Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. South Korea Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Thailand Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.5.3. Competitive Scenario
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 8.2. Company/ Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Bruker
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. GE HealthCare
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Siemens Healthineers AG
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Koninklijke Philips N.V.
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Canon Medical Systems Corporation
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Mediso Ltd.
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Cubresa Inc.
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Shimadzu Corporation
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. United Imaging Healthcare Co., Ltd.
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Positron
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Molecular Imaging Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 5 Global Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7 North America Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 9 North America Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 10 North America Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 12 U.S. Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 15 Canada Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 18 Mexico Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Mexico Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 22 Europe Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 23 Europe Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24 U.K. Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 25 U.K. Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 26 U.K. Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Germany Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 28 Germany Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Germany Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 31 France Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 France Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 34 Italy Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 35 Italy Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 37 Spain Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 38 Spain Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 40 Denmark Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 Denmark Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 43 Sweden Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Norway Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 46 Norway Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 47 Norway Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 53 Japan Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 54 Japan Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 China Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 56 China Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 57 China Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 59 India Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 India Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Australia Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 62 Australia Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 63 Australia Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 64 South Korea Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 65 South Korea Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 66 South Korea Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 68 Thailand Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 Thailand Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 72 Latin America Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Latin America Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 75 Brazil Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 76 Brazil Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 78 Argentina Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 85 South Africa Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 90 UAE Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 91 UAE Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 92 UAE Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Molecular Imaging Market: Market Outlook
  • Fig. 10 Molecular Imaging Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Molecular Imaging Market Driver Impact
  • Fig. 16 Molecular Imaging Market Restraint Impact
  • Fig. 17 Molecular Imaging Market Strategic Initiatives Analysis
  • Fig. 18 Molecular Imaging Market: Modality Movement Analysis
  • Fig. 19 Molecular Imaging Market: Modality Outlook and Key Takeaways
  • Fig. 20 Molecular Ultrasound Imaging Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Positron Emission Tomography (PET) Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Single Photon Emission Computed Tomography (SPECT) Market Estimates and Forecast, 2018 - 2030
  • Fig. 23 Nuclear Magnetic Resonance (NMR) Spectrometer Market Estimates and Forecast, 2018 - 2030
  • Fig. 24 Others Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 Molecular Imaging Market: Application Movement Analysis
  • Fig. 26 Molecular Imaging Market: Application Outlook and Key Takeaways
  • Fig. 27 Cardiovascular Market, 2018 - 2030 (USD Million)
  • Fig. 28 Neurology Market, 2018 - 2030 (USD Million)
  • Fig. 29 Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 30 Respiratory Market, 2018 - 2030 (USD Million)
  • Fig. 31 Gastrointestinal Market, 2018 - 2030 (USD Million)
  • Fig. 32 Molecular Imaging Market: End Use Movement Analysis
  • Fig. 33 Molecular Imaging Market: End Use Outlook and Key Takeaways
  • Fig. 34 Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 35 Diagnostic Imaging Centers Market, 2018 - 2030 (USD Million)
  • Fig. 36 Research Institutes Market, 2018 - 2030 (USD Million)
  • Fig. 37 Global Molecular Imaging Market: Regional Movement Analysis
  • Fig. 31 Global Molecular Imaging Market: Regional Outlook and Key Takeaways
  • Fig. 38 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 U.K. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 65 Kuwait Market Estimates and Forecasts, 2018 - 2030